تحميل...
PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions
Ovarian cancer is the fifth leading cause of female cancer deaths in the Western world. Significant progress has been made in the treatment of patients with ovarian cancer, however, the majority of patients experience disease recurrence and new therapies are being sought for such patients. Clinical...
محفوظ في:
| الحاوية / القاعدة: | Br J Cancer |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Nature Publishing Group
2015
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4816268/ https://ncbi.nlm.nih.gov/pubmed/26669450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.395 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|